The First 1,000 Days Program: Maternal-Child Obesity Prevention in Early Life

December 19, 2025 updated by: Elsie Taveras, MD, Massachusetts General Hospital

The First 1000 Days (conception to age 2) is a crucial period for the development and prevention of obesity and its adverse consequences in mother-child pairs and their families. The overall aim of the First 1000 Days program is to work across early-life systems to prevent obesity, promote healthy routines and behaviors, address social determinants of health, and reduce health disparities among vulnerable children and families at community health centers in the Boston, MA area.

The study aims to simultaneously implement and evaluate an obesity prevention program across early life systems to reduce the prevalence of obesity risk factors within racial/ethnic minority families, close the gap in maternal-child health disparities, and assess and address social determinants of health.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

1645

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All pregnant women receiving prenatal care at select community health centers in the Boston, MA area
  • All families of children aged 0-2 years receiving pediatric care at select community health centers in the Boston, MA area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: First 1,000 Days Program
Program components will include 1) Enhancements to and improved use of electronic health records to improve the quality of preventive services and screening for social determinants of health; 2) Staff and provider training; 3) Consistent behavior change messaging; 4) Patient education via print materials, text messaging and short videos; and 5) Strengthening the integration of clinical and public health services to support behavior change and address social determinants of health.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Gestational Weight Gain
Time Frame: First prenatal care visit to 36 weeks gestation
Weight gained during pregnancy
First prenatal care visit to 36 weeks gestation
Infant Weight-for-Length Z-Score
Time Frame: Child age 6 months
Age- and sex-specific weight-for-length z-score
Child age 6 months
Infant Weight-for-Length Z-score
Time Frame: Child age 12 months
Age- and sex-specific weight-for-length z-score
Child age 12 months
Infant Weight-for-Length Z-Score
Time Frame: Child age 24 months
Age- and sex-specific weight-for-length z-score
Child age 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from 1st trimester maternal diet to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
Average weekly intake
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester maternal physical activity to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
Days per week physically active for at least 30 minutes per day
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester maternal sleep duration to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
Average hours per day
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester maternal sedentary time to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
Hours per day of screentime
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester depression to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
Edinburgh Postnatal Depression Scale
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester maternal food insecurity to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
2-question validated scale
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester maternal housing insecurity to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
2-question validated scale
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester pregnancy-related anxiety to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
5-question validated scale
An average of 18 weeks (1st trimester to 3rd trimester)
Change from 1st trimester enrollment in food assistance programs to 3rd trimester
Time Frame: An average of 18 weeks (1st trimester to 3rd trimester)
Yes/No response options for program enrollment in WIC and SNAP
An average of 18 weeks (1st trimester to 3rd trimester)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elsie Taveras, MD, MPH, Massachusetts General Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 9, 2016

Primary Completion (Actual)

March 18, 2021

Study Completion (Actual)

March 18, 2021

Study Registration Dates

First Submitted

June 9, 2017

First Submitted That Met QC Criteria

June 15, 2017

First Posted (Actual)

June 19, 2017

Study Record Updates

Last Update Posted (Estimated)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on First 1,000 Days Program Site

Subscribe